Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. IGEA Pharma N.V.
  6. Company
    IGPH   NL0012768675

IGEA PHARMA N.V.

(IGPH)
SummaryQuotesChartsNewsCompanyFinancials 
Business Summary
IGEA Pharma NV is a biopharmaceutical company based in the Netherlands. The Company focuses on research and development of biomedical solutions for the prevention of diabetes and Alzheimer's disease. Its offering portfolio includes medical testing devices and dietary supplements. The Company develops ALZ-1 Test, a blood test to measure and control level of free copper, also known as Free Copper II or Non-Ceruloplasmin Copper in the bloodstream, which is a major recognized modifiable risk factor for the AlzheimerÔÇÖs disease. The Company offers its services in the Netherlands.
Managers
Name Title Age Since
Vicenzo Moccia Chairman-Management Board 60 -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 332,919,397 330,750,956 99.3% 0 0.0% 99.3%
Shareholders
NameEquities%
Pharma Tech Holding SA 101,944,500 30.6%
Pierpaolo Cerani 30,365,010 9.12%
Cristina Canepa 26,700,000 8.02%
Olivetree Foundation 748,958 0.22%
Diego Mortillaro 218,441 0.066%
Chart AG 48,766 0.015%
Lemanik SA 31,872 0.0096%
Company contact information
IGEA Pharma NV
Siriusdreef 17
Hoofddorp, Noord-Holland 2132 WT

Phone : +31.23.568.94.94
Web : http://www.igeapharma.nl
Brand Portfolio
In partnership withAllbrands.markets
More brands of IGEA Pharma N.V.